| Brief |
RadiRad, founded in 2021 and headquartered in New Taipei City, Taiwan, is a dynamic healthcare AI and digital health company. We are dedicated to developing innovative, data-driven solutions that harness the power of deep learning, medical image analysis, and physiological signal quantification. Our journey began with a commitment to address two pivotal clinical challenges: the increasing demand for continuous monitoring for patients with chronic and cardiovascular conditions, and the historically time-intensive, labor-intensive, and difficult-to-standardize process of quantitative spine MRI assessment. RadiRad's fundamental mission is to transform complex clinical data into actionable insights, enabling healthcare professionals to deepen their understanding of patient conditions, improve diagnostic consistency, and foster personalized, proactive care.Our product portfolio is intelligently structured around two key platforms: RadiHeart and RadiSpine. RadiHeart is specifically designed for cardiac and physiological health management, utilizing advanced AI applications on PPG and related physiological signals. Its capabilities and development areas encompass continuous blood pressure monitoring, heart rate variability analysis, arrhythmia detection, and comprehensive cardiac function evaluation. RadiSpine applies AI-driven segmentation and quantitative analysis to spinal MRI data, facilitating a more efficient assessment of intervertebral discs, dura sacs, and other vital spinal structures. By seamlessly integrating data acquisition, AI analytics, quantitative outputs, and automated reporting into a streamlined clinical workflow, RadiRad is steadfast in its aim to make healthcare more precise, standardized, scalable, and data-driven. We are also strategically expanding our presence in international markets, with an initial focus on Japan and Europe, and a continued commitment to growth in North America and Southeast Asia. |
